Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIDEC: SCIG vs IVIG in Treatment-naïve CIDP
NCT04589299Phase 4Recruiting
- Sponsor
- Aarhus University
- Start
- Jun 2020
- Primary completion
- Dec 2030
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of polyvalent human immunoglobulin in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by Aarhus University. Started Jun 2020; status: recruiting.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT04589299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589299.